Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06024473 · ClinicalTrials.gov registry record · NA

A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI

A NA study of Mild Cognitive Impairment and Quality of Life, sponsored by Central Arkansas Veterans Healthcare System.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06024473: Recruiting NA study of Mild Cognitive Impairment and Quality of Life, sponsored by Central Arkansas Veterans Healthcare System.

NCT06024473 is a NA study of Mild Cognitive Impairment and Quality of Life that is actively recruiting participants, run by Central Arkansas Veterans Healthcare System. The registered enrollment target is 50 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06024473, a NA study of Mild Cognitive Impairment and Quality of Life, is actively recruiting participants, sponsored by Central Arkansas Veterans Healthcare System.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical trial is being conducted to see if brain stimulation and brain training together improves cognitive functioning and mood in older adults diagnosed with Mild Cognitive Impairment (MCI). Brain stimulation will be done using repetitive Transcranial Magnetic Stimulation (rTMS). Brain training will be done using immersive virtual reality cognitive training (iVCT) program. The goals of this clinical trail are as follows: * Examine if rTMS+iVCT intervention can improve and sustain objective cognitive functioning in individuals with MCI more than control or rTMS only groups * Examine if rTMS+iVCT intervention improves participants mental health symptoms, functional abilities, and quality of life more than control or rTMS only groups * Examine the impact of rTMS+iVCT intervention on caregiver burden. Eligible participants will be assigned to a standard treatment (no intervention control) group, rTMS only group of rTMS+iVCT group. All participants will undergo baseline assessment to evaluate their cognitive, emotional, and functional abilities. Those in the rTMS only group will receive rTMS treatments for five days per week for two weeks (total of ten sessions). Those in the rTMS+iVCT group will receive rTMS treatment followed by iVCT training for five days a week for two weeks (total of ten sessions). All participants will then repeat testing 2 weeks and three months after baseline testing to assess for possible treatment related changes and lasting effects.

Primary Outcome

range: \<55 to \>130 - higher score is improvement

Conditions Studied

Mild Cognitive Impairment Quality of Life Mental Health Issue Caregiver Burden ADL

Interventions

  • DEVICE rTMS
  • DEVICE rTMS+iVCT

Study Locations (1)

Arkansas

  • Central Arkansas VA Healthcare system - Little Rock

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-03-31
Est. Completion 2026-09
Phase NA
Central Arkansas Veterans Healthcare System

9 total trials

What NCT06024473 shows while recruiting

NCT06024473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (96% lower).

The record links to 5 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which rTMS is the first listed.

NCT06024473 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT06024473 about?

NCT06024473 is a clinical study titled "A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI". This clinical trial is being conducted to see if brain stimulation and brain training together improves cognitive functioning and mood in older adults diagnosed with Mild Cognitive Impairment (MCI). Brain stimulation will be done using repetitive Transcranial Magnetic Stimulation (rTMS). Brain train...

What is the current status of trial NCT06024473?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-03-31. Estimated completion is 2026-09.

What conditions does trial NCT06024473 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Quality of Life, Mental Health Issue, Caregiver Burden, ADL.

What interventions are being tested in trial NCT06024473?

The interventions under investigation include: rTMS (DEVICE), rTMS+iVCT (DEVICE).

Who is sponsoring clinical trial NCT06024473?

This trial is sponsored by Central Arkansas Veterans Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06024473 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06024473's enrollment target sits among peer trials

50 140th of 205 higher than 62 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06024473

Source: ClinicalTrials.gov NCT06024473, the US trial registry maintained by the National Library of Medicine. NCT06024473 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.